Trials / Completed
CompletedNCT02100917
Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Meiji Seika Pharma Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
This study is a randomized Trastuzumab-controlled double-blind parallel-group study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DMB-3111 | |
| DRUG | trastuzumab |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-05-01
- Completion
- 2014-12-01
- First posted
- 2014-04-01
- Last updated
- 2015-02-10
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02100917. Inclusion in this directory is not an endorsement.